Carrolee Barlow serves as Executive at SUPERNUS PHARMACEUTICALS, INC., where they oversee executive responsibilities. Since joining the company, Carrolee Barlow has executed 4 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 23, 2024 involved receiving (via award) 3,886 shares valued at $0.
Carrolee Barlow currently holds 17,201 shares of SUPERNUS PHARMACEUTICALS, INC. (SUPN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Carrolee Barlow has been a net neutral trader of SUPN stock. They have purchased $0 and sold $0 worth of shares.
Carrolee Barlow's most recent insider trade was on Feb 23, 2024, when they sold 3,886 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Feb 19, 2022 | SUPN | $0 | Award | 4,222 | $N/A | Discretionary |
| Feb 21, 2020 | SUPN | $125.0K | Award | 5,211 | $23.99 | Discretionary |